SRKW Announces Roll-Back of Drug Prices and Final Approval of $350 Million McKesson Settlement

SRKW is pleased to announce that a price roll-back for hundreds of prescription drugs has occurred as scheduled on September 26. The roll-back of Average Wholesale Price (“AWP”) mark-ups was obtained as part of settlements with First DataBank and Medi-Span, publishers of AWP prices. SRKW successfully defended this settlement against legal challenges all the way to the U.S. Supreme Court.

SRKW and its co-lead counsel have also obtained final Court approval for the $350 million cash settlement with defendant McKesson, for its part in the AWP manipulation scheme. The settlement funds will be divided between consumers and health plans that over paid for prescription drugs at prices based on fraudulent AWPs.